CALQUENCE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Aug 03, 2022

   3 yr 11 mo ago

2. Today

3. Patent 7459554 expires

   Listed drug substance patent expiration.

   Nov 24, 2026

   in 5 mo

4. Exclusivity ends · I-960

   New indication exclusivity (3 years)

   Jan 16, 2028

   in 1 yr 7 mo

5. Exclusivity ends · D-200

   New indication / change exclusivity (3 years)

   Feb 19, 2029

   in 2 yr 9 mo

6. Patent 10239883 expires

   Listed method-of-use patent (U-2666) expiration.

   Jul 11, 2032

   in 6 yr 2 mo

7. Patent 10239883 expires

   Listed method-of-use patent (U-2668) expiration.

   Jul 11, 2032

   in 6 yr 2 mo

8. Patent 9290504 expires

   Listed drug substance patent expiration.

   Jul 11, 2032

   in 6 yr 2 mo

9. Patent 9758524 expires

   Listed method-of-use patent (U-4108) expiration.

   Jul 11, 2032

   in 6 yr 2 mo

10. Patent 9758524 expires

    Listed method-of-use patent (U-2145) expiration.

    Jul 11, 2032

    in 6 yr 2 mo

11. Patent 10272083 expires

    Listed method-of-use patent (U-4109) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

12. Patent 10272083 expires

    Listed method-of-use patent (U-2519) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

13. Patent 10272083 expires

    Listed method-of-use patent (U-2682) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

14. Patent 10272083 expires

    Listed method-of-use patent (U-2683) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

15. Patent 10272083 expires

    Listed method-of-use patent (U-2684) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

16. Patent 10272083 expires

    Listed method-of-use patent (U-2685) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

17. Patent 10272083 expires

    Listed method-of-use patent (U-2686) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

18. Patent 10272083 expires

    Listed method-of-use patent (U-2687) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

19. Patent 11771696 expires

    Listed method-of-use patent (U-3710) expiration.

    Jan 21, 2035

    in 8 yr 9 mo

20. Patent 11166951 expires

    Listed method-of-use patent (U-4426) expiration.

    Aug 11, 2035

    in 9 yr 3 mo

21. Patent 11166951 expires

    Listed method-of-use patent (U-4427) expiration.

    Aug 11, 2035

    in 9 yr 3 mo

22. Patent 11166951 expires

    Listed method-of-use patent (U-4428) expiration.

    Aug 11, 2035

    in 9 yr 3 mo

23. Patent 11166951 expires

    Listed method-of-use patent (U-4429) expiration.

    Aug 11, 2035

    in 9 yr 3 mo

24. Patent 11166951 expires

    Listed method-of-use patent (U-4430) expiration.

    Aug 11, 2035

    in 9 yr 3 mo

25. Patent 11166951 expires

    Listed method-of-use patent (U-4431) expiration.

    Aug 11, 2035

    in 9 yr 3 mo

26. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

27. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

28. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

29. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

30. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

31. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

32. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

33. Patent 11059829 expires

    Listed drug substance patent expiration.

    Jul 01, 2036

    in 10 yr 2 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

• I-960New indication exclusivity (3 years)

  Jan 16, 2028

  in 1 yr 7 mo

• D-200New indication / change exclusivity (3 years)

  Feb 19, 2029

  in 2 yr 9 mo

Listed patents (29)